CTA-PB — EIDP, Inc. USD 4.50 Cum Pfd Registered Shs

Corteva Agriscience Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Net Sales: $6.4 billion for Q2; $11.3 billion for the first half, a 4% increase year-over-year.
• Operating EBITDA: $2.3 billion for Q2; $3.7 billion for the first half, reflecting a 10% increase year-over-year.
• Operating EPS: Increased by 14% in the first half, with guidance raised to $3.60 to $3.80 per share for the full year.
• EBITDA Margin: Expanded to 32.8% in the first half, driven by productivity improvements and disciplined cost management.

2. Strategic Updates and Business Highlights

• Separation Progress: On track to complete the separation into two independent companies by October 1, 2026, with significant milestones achieved, including leadership appointments and the filing of Form 10.
• Seed Business: Strong demand for differentiated technologies and new licensing business contributed to organic growth across all regions.
• Crop Protection: Continued volume growth from new products, with a focus on innovation and operational discipline. The company is enhancing its portfolio with nature-based products.
• R&D Investment: Nearly $9 billion invested in R&D since Corteva's formation, with a strong innovation pipeline including seven new active ingredients expected over the next decade.

3. Forward Guidance and Outlook

• Full-Year Operating EBITDA: Raised to a range of $4.1 billion to $4.3 billion, representing approximately 9% growth at the midpoint versus the previous year.
• Operating EBITDA Margin: Increased guidance to 22.5% to 23.5%.
• Second Half Expectations: Anticipated flat EBITDA compared to the previous year, with a typical seasonal earnings pattern expected, primarily weighted towards Q4.

4. Bad News, Challenges, or Points of Concern

• Pricing Pressure: Crop protection pricing is expected to decline in the low to mid-single digits due to competitive market dynamics, particularly in Latin America.
• Farmer Margins: Farmers are facing tight margins, leading to cautious discretionary spending and impacting order patterns.
• Geopolitical and Economic Risks: Ongoing geopolitical uncertainties and currency fluctuations are potential risks that could affect performance.
• Dyssynergies: A $25 million headwind anticipated due to separation activities, although largely offset by operational efficiencies.

5. Notable Q&A Insights

• Seed Business Outlook: Expectations for flat corn acres in Brazil, with confidence in order books and product portfolio strength.
• Market Dynamics: Discussions highlighted the competitive pressure in crop protection pricing, particularly in Brazil, and the company's strategies to maintain margins despite this.
• Long-Term Growth: Leadership expressed confidence in achieving mid-single-digit growth rates into 2027, driven by strong product adoption and operational efficiencies.
• Product Pipeline: Excitement around the strong R&D pipeline, particularly in differentiated products and biologicals, was emphasized as a key competitive advantage.

Overall, Corteva demonstrated solid financial performance and strategic execution in Q2 2026, while navigating challenges related to pricing pressures and market dynamics. The company remains optimistic about its growth trajectory and the successful separation into two independent entities.